Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019204 (
hepatocellular carcinoma
)
71,386
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Kruppel-like factor 4 (KLF4), a member of the KLF family of transcription factors, has been considered as a crucial tumor suppressor in
hepatocellular carcinoma
(
HCC
). Using affinity purifications and mass spectrometry, we identified
FBXO22
, Cullin1 and SKP1 as interacting proteins of KLF4. We demonstrate that
F-box only protein 22
(
FBXO22
) interacts with and thereby destabilizes KLF4 via polyubiquitination. As a result,
FBXO22
could promote
HCC
cells proliferation both in vitro and in vivo. However, KLF4 deficiency largely blocked the proliferative roles of
FBXO22
. Importantly,
FBXO22
expression was markedly increased in human
HCC
tissues, which was correlated with down-regulation of KLF4. Therefore, our results suggest that
FBXO22
might be a major regulator of
HCC
development through direct degradation of KLF4.
...
PMID:F-box protein FBXO22 mediates polyubiquitination and degradation of KLF4 to promote hepatocellular carcinoma progression. 2608 83